CAS: 846-48-0; Boldenone

该化合物是睾丸酮产生的代谢类类固醇,其特点是化学结构,包括第一和第二碳原子之间的双重结合,将其与睾丸酮区分开来.这种改变会增加其代谢性能,同时减少和诱因效应.Boldenone以促进肌肉生长,增加食欲和改善体内的氮保留为名,使其在兽医治疗牲畜的药物中很受欢迎.该物质经常用于身体建设和运动圈,以提高性能和生理能力.该物质的半衰期相对较长,在施用时允许产生持续影响.然而,其使用与潜在的副作用有关,包括荷尔蒙失衡,心血管问题和肝毒性.Boldenone在许多国家被归类为受控物质,而且各种体育组织因其性能增强效应而禁止在竞争性体育中使用.在考虑使用任何代谢类类固醇时,建议谨慎和医疗监督.

结构式图片

欧盟法规

REACH注册ECHA物质ECHA物质C&L通报REACH预注册

上下游产品

2,4,6-trimethyl-pyridine 2α,4α-dibromo-17β-hydroxy-5α-androstan-3-one testosterone progesteroneestradiol 4-methyl-estratriene-(1.3.5(10))-diol-(1.17β) Estrone Androsta-1,4-diene-3,17-dione

合成工艺路线路线简述

  • 合成目标产物 Boldenone 主要起始原料 Beta-Sitosterol
  • 897-06-3 = 846-48-0
    反应条件:1.1 Reagents: Sodium Borohydride Solvents: Ethanol,Water; 0.25 H,22 °C1.2 Reagents: Hydrochloric Acid Solvents: Ethyl Acetate,Water; Acidified1.3 Reagents: Sodium Bicarbonate Solvents: Water; Neutralized
    标题:Reduction Of Steroidal Ketones With Amine-Boranes
    作者:Leontjev,A. E.; Vasiljeva,L. L.; Pivnitsky,K. K.
    参考文献:Russian Chemical Bulletin (Translation Of Izvestiya Akademii Nauk 日期:2004 卷标:53(3) 页码:703-708]

    977-32-2 = 846-48-0
    反应条件:1.1 Reagents: Potassium Carbonate Solvents: Methanol; 10 H,Rt
    标题:An Efficient And Environmentally Benign Chemical Synthesis Of Testolactone
    作者:Zinczuk,Juan; Bacigaluppo,Jose A.; Colombo,Maria I.; Cravero,Raquel M.; Gonzalez-Sierra,Manuel; Et Al
    参考文献:Journal Of The Brazilian Chemical Society 日期:2003 卷标:14(6) 页码:970-974]

    2363-59-9 = 846-48-0
    反应条件:1.1 Reagents: Sodium Hydroxide Solvents: Methanol1.2 Reagents: Hydrochloric Acid1.3 Solvents: Dichloromethane
    标题:Synthetic Studies Toward 1α-Hydroxytestosterone From Testosterone
    作者:Gao,Hongwu; Dias,Jerry Ray
    参考文献:Proceedings Of Ecsoc-3 日期:2000 卷标:1214 页码:1214-1228]

    58-22-0 = 846-48-0
    反应条件:1.1 Reagents: 2,3-Dichloro-5,6-Dicyano-1,4-Benzoquinone Catalysts: Tert-Butyldimethylsilyl Chloride Solvents: 1,4-Dioxane; 0 °C; 40 H,0 °C -> Rt
    标题:A Practical δ1-Dehydrogenation Of δ4-3-Ketosteroids With Ddq In The Presence Of Tbdmscl At Room Temperature
    作者:Chen,Kaixiong; Liu,Chang; Deng,Le; Xu,Guangyu
    参考文献:Steroids 日期:2010 卷标:75(7) 页码:513-516]

    17086-53-2 = 846-48-0
    反应条件:1.1 Reagents: 2,3-Dichloro-5,6-Dicyano-1,4-Benzoquinone
    标题:New Reagent For Selective Oxidation Of Steroidal Allylic Alcohols To αβ-Unsaturated Ketones
    作者:Burn,D.; Petrow,V.; Weston,G. O.
    参考文献:Tetrahedron Letters 日期:1960 卷标:14 页码:14-15]

    897-06-3 = 846-48-0
    反应条件:1.1 Reagents: Glucose Catalysts: 3(17)β-Hydroxysteroid Dehydrogenase Solvents: Ethanol,Water; 96 H,24 - 26 °C
    标题:Formation Of 5α Steroids By Biotransformation Involving The 5α-Reductase Activity Of Penicillium Decumbens
    作者:Holland,Herbert L.; Dore,Sophia; Brown,Frances M.
    参考文献:Steroids 日期:1994 卷标:59(11) 页码:642-7]

    897-06-3 = 846-48-0
    反应条件:1.1 Reagents: Sodium Borohydride Solvents: Dimethylformamide,Water
    标题:Preparation Of 3-Oxo-17-Hydroxy Steroids
    参考文献:German Democratic Republic]

    58-22-0 = 846-48-0
    反应条件:1.1 Reagents: Tert-Butyldimethylsilyl Chloride Solvents: Tetrahydrofuran,1,4-Dioxane; Rt -> 0 °C; 90 Min,0 °C1.2 Reagents: 2,3-Dichloro-5,6-Dicyano-1,4-Benzoquinone Solvents: Tetrahydrofuran,1,4-Dioxane; 4 H,0 °C; 12 H,0 °C -> Rt
    标题:Novel Protective Group Synthesis Of Androgen Receptor Modulators With Steroidal And Nonsteroidal Scaffolds
    作者:Grill,Matthias; Patt,Melanie; Odermatt,Alex
    参考文献:Chemrxiv 日期:2019 卷标:1 页码:1-13]

    897-06-3 = 846-48-0
    反应条件:1.1 Solvents: Ethanol,Water; 7 D,25 °C
    标题:Nostoc Muscorum: A Regioselective Biocatalyst For 17-Carbonyl Reduction Of Androst-4-En-3,17-Dione And Androst-1,4-Dien-3,17-Dione
    作者:Faramarzi,Mohammad Ali; Yazdi,Mojtaba Tabatabaei; Ghostinroudi,Hadi; Amini,Mohsen; Ghasemi,Younes; Et Al
    参考文献:Annals Of Microbiology (Milano 日期:2006 卷标:56(3) 页码:253-256]

    63-05-8 = 846-48-0
    反应条件:1.1 Catalysts: 3(17)β-Hydroxysteroid Dehydrogenase,17β-Hydroxysteroid Dehydrogenase Solvents: Water; 12 H,25 °C
    标题:Study On Catalytic Synthesis Of Boldenone By Recombinant E. Coli Expressing 17β-Hydroxysteroid Dehydrogenase
    作者:Wu,Yuling; Shao,Minglong; Zhou,Wulin; Gao,Huifang; Zhang,Xian; Et Al
    参考文献:Huagong Xuebao (Chinese Edition) 日期:2020 卷标:71(7) 页码:3229-3237]

    58-22-0 = 846-48-0
    反应条件:1.1 Reagents: Oxygen Catalysts: Nadph-Dehydrogenase Solvents: Water; 48 H,Ph 7,70 °C
    标题:Old Yellow Enzyme-Catalyzed Dehydrogenation Of Saturated Ketones
    作者:Schittmayer,Matthias; Glieder,Anton; Uhl,Michael K.; Winkler,Andreas; Zach,Simone; Et Al
    参考文献:Advanced Synthesis & Catalysis 日期:2011 卷标:353 页码:268-274]

    897-06-3 = 846-48-0
    反应条件:1.1 Reagents: Nadph,Oxygen Solvents: Acetone,Water; 1 H,Ph 5.5,30 °C
    标题:Asymmetric Reduction Of Prochiral Ketones By Cell-Free Systems From Alcaligenes Eutrophus
    作者:Madyastha,Kattigere M.; Gururaja,Tarikere L.
    参考文献:Journal Of Chemical Technology And Biotechnology 日期:1994 卷标:59(3) 页码:249-55
📜睾酮置于old Yellow Enzyme From Geobacillus Kaustophilus体系中,化学反应 48.0H,反应生成 宝丹酮
参考文献:老黄酶催化的饱和酮脱氢
标题:老黄酶催化的饱和酮脱氢
摘要:极端微生物的酶由于对各种应激因素的耐受性而一直对生物技术非常感兴趣.我们已经分离,克隆,异源表达并表征了来自嗜碱芽孢杆菌的热稳定的旧黄色酶(oye).除预期的"烯酮"还原外,Gk Oye还催化逆反应,即与羰基相邻的cc键脱饱和,得到相应的α,β-不饱和酮.该反应以分子氧为代价而无需烟酰胺辅因子进行,并且代表了对已知化学脱氢方法的环境友好的替代方案.
DOI:10.1002/adsc.201000862

海关参考信息

专利信息


专利号:US-2014378538-A1
优先权日:2011-12-14
标 题:Methods of responding to a biothreat
发明人:BANCEL STEPHANE
权利人:MODERMA THERAPEUTICS INC
摘要:The present disclosure provides for devices, in particular mobile devices, which may be used in the synthesis of modified nucleic acid molecules, in particular modified mRNA molecules. The device for making the modified nucleosides, modified nucleotides and modified nucleic acids (e.g., mRNA) disclosed herein may be mobile devices comprising at least one sample block for insertion of one or more sample vessels, a device base with electronic control units for the sample block, a voltage supply, and one or more reagent(s) for the synthesis of at least one nucleic acid.

专利号:US-2004137081-A1
优先权日:2003-01-13
标题 :Attaining sexual wellness and health of the sexual vascular system with proanthocyanidins
发明人:ROHDEWALD PETER; FERRARI VICTOR
摘要:Sexual wellness or sexual fitness is enhanced over time by administrating on a daily basis a source of proanthocyanidins and a source of arginine. Both sources may be blended into a composition or taken separately from a kit. The source of arginine may be a salt or peptide of L-arginine and aspartic acid such as arginine aspartate. The proanthocyanidins stimulate an endothelial NO-synthase enzyme, which serves as a catalyst for synthesis of the nitric oxide from a substration that is the source of the arginine. A sufficient amount of the nitric oxide is released over time to enhance sexual wellness or sexual fitness. In case of low levels of androgenic hormones in both sexes, the combination may contain as a further ingredient a sex hormone or a sex hormone precursor or a sex hormone stimulant or a sex hormone bioavailability enhancer.

专利号:US-2005171030-A1
优先权日:2000-05-26
标题:Relieving symptoms of erectile dysfunction and attaining sexual wellness and health of the sexual vascular system with proanthocyanidins
发明人:ROHDEWALD PETER; FERRARI VICTOR
摘要:Sexual wellness or sexual fitness is enhanced over time by administrating on a daily basis a source of proanthocyanidins and a source of arginine. Both sources may be blended into a composition or taken separately from a kit. The source of arginine may be a salt or peptide of L-arginine and aspartic acid such as arginine aspartate. The proanthocyanidins stimulate an endothelial NO-synthase enzyme, which serves as a catalyst for synthesis of the nitric oxide from a substration that is the source of the arginine. A sufficient amount of the nitric oxide is released over time to enhance sexual wellness or sexual fitness. In case of low levels of androgenic hormones in both sexes, the combination may contain as a further ingredient a sex hormone or a sex hormone precursor or a sex hormone stimulant or a sex hormone bioavailability enhancer.

专利号:US-11649285-B2
优先权日:2016-08-03
标题 :Identification of VSIG3/VISTA as a novel immune checkpoint and use thereof for immunotherapy
发明人:KALABOKIS VASSILIOS; WANG JINGHUA; WU GUOPING; BAZAN JOSE FERNANDO; VALLEY CHRISTOPHER CARLIN
权利人:BIO TECHNE CORP
摘要:The ligand for VISTA is identified (VSIG3) as well as the use of this ligand and receptor interaction in the identification or synthesis of a VSIG3 agonist or antagonist compounds, preferably antibodies, polypeptides and fusion proteins which agonize or antagonize the effects of VSIG3 and/or VISTA and/or the VSIG3/VISTA interaction. These antagonists may be used to suppress VSIG3/VISTA's suppressive effects on T cell immunity, and more particularly used in the treatment of cancer, or infectious disease. These agonist compounds may be used to potentiate or enhance VSIG3/VISTA's suppressive effects on T cell immunity and thereby suppress T cell immunity, such as in the treatment of autoimmunity, allergy or inflammatory conditions. Screening assays for identifying these agonists and antagonist compounds are also provided.

专利号:US-2023212216-A1
优先权日:2019-12-20
标 题:Synthesis of lactone derivatives and their use in the modification of proteins
发明人:MORRIS ALEXANDER REDFERN; SUTOV GRIGORIJ; BRUNE KARL DIETRICH
权利人:GENIE BIOTECH UK LTD
摘要:Site-specific modifications of proteins are desirable in biotechnological applications such as biopharmaceuticals, immunotherapy, vaccines, and are useful in chemical biology. Gluconoylation is a non-enzymatic, covalent, post-translational modification commonly observed on N-terminal His-Tags bearing proteins. We synthesized glucono-1,5-lactone derivatives, including azido variants for selective acylation. High yield acylation is achieved by simply mixing derivatives with target protein amidst diverse conditions of temperatures, aqueous buffers, excipients, or complex cell lysate.

专利号:US-2008267981-A1
优先权日:2004-06-30
标题:Compositions and Methods for Delivery of Antitumor Agents
发明人:JANDA KIM D; WIRSCHING PETER; BOGER DALE L
权利人:SCRIPPS RESEARCH INST
摘要:Methods for treating a neoplastic disease with an antibody-cytotoxin conjugate molecule, methods of synthesizing an antibody-cytotoxin conjugate molecule are provided. Compounds that are useful as antibody-cytotoxin conjugate molecule or useful in the synthesis of these molecules are also provided.

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


参考文献:10.1186/1746-6148-7-39
摘要:Jana K, Samanta PK. Clinical Evaluation of Non-surgical Sterilization of Male Cats with Single Intra-testicular Injection of Calcium Chloride. BMC Veterinary Research. 2011 Jul 21;7(1):39. doi: 10.1186/1746-6148-7-39.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知